RFK Jr. has shut down the Office of Long COVID Research and Practice, gutted funding, and derailed trials and studies.

Flu season is here. The summer wave of the coronavirus has receded, but the winter uptick is likely around the corner. Shots ...

Pfizer's new COVID vaccine shows promising results with 4x immunity boost, but Kennedy's restrictions leave most Americans ...

After a chaotic year that has seen the attrition of over half the FDA’s senior leadership, many of these individuals have ...

Interstitial Lung Disease (ILD): In the PHAROS trial, 1 patient (1%) receiving MEKTOVI with BRAFTOVI developed pneumonitis. Assess new or progressive unexplained pulmonary symptoms or findings for ...

A vaccine originally designed to protect against Covid-19 has shown unexpected promise in helping the immune system fight ...

Covid vaccines may come with a tantalizing benefit that has nothing to do with the virus they’re designed to protect against: ...

An analysis of patient records suggests that mRNA covid-19 vaccines boost the immune response to cancerous tumours when given ...

Patients with advanced lung or skin cancer who received a COVID-19 mRNA vaccine within 100 days of starting immunotherapy ...

Pfizer is backed by strong H1 results, a promising pipeline, improved financials, and solid valuation with long-term growth ...

The FDA wants to reevaluate the use of aluminum adjuvants despite a long record of safe use in vaccines President Donald ...

Moderna, Inc. remains under pressure in 2025, despite recent next-gen COVID vaccine approval & cancer vaccine trial. Learn ...